Stage CTC CEA NSE CYFRA21-1 SCCA
ALL81%34%25%50%30%
Stage I67%11%6% 29%9%
Stage II71%30%6% 55%25%
Stage III、IV86%37%30%52%30%

肺癌辅助诊断

I 期肺癌检测敏感度 67%
肺癌总体检测敏感度80%
肺癌总体检测特异度88%

治疗疗效评估

评估肿瘤活性状态,弥补RECIST标准的不足,治疗方案选择更精准

术后监测复发

动态随访,辅助胸部CT,及时预警复发